Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial.

Muhammad KaryanaIrawaty DjaharuddinLutfah Rif'atiMansyur ArifMi Kyung ChoiNova AngginyAeri YoonJumi HanFonny JoshDona ArlindaAsvin NarulitaFaisal MuchtarRizki Auliah BakriS Irmansyah

Published in: Stem cell research & therapy (2022)

ClinicalTrials.gov, NCT04535856. Registered 2 September 2020, https://clinicaltrials.gov/ct2/show/NCT04535856.

Keyphrases

double blind
placebo controlled
clinical trial
study protocol
computed tomography
low dose
image quality
contrast enhanced
dual energy
phase iii
phase ii
magnetic resonance imaging
magnetic resonance